Use of the FebriDx® host-response point-of-care test may reduce antibiotic use for respiratory tract infections in primary care: a mixed-methods feasibility study.

Christopher R WilcoxNour OdehTristan W ClarkIngrid MullerTaeko BecqueAlexander ToddNazrul IslamPaul LittleFiroza DaviesJohn McGavinNick A Francis

Published in: The Journal of antimicrobial chemotherapy (2024)

Use of FebriDx® to guide antibiotic prescribing for LRTI in primary care was associated with a substantial reduction in prescribing intentions. These results support a fully powered RCT to confirm its impact and safety.

Keyphrases

primary care
respiratory tract
general practice
study protocol
clinical trial